Agilent Technologies, Inc. $A Shares Sold by US Bancorp DE

US Bancorp DE lowered its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 2.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 58,821 shares of the medical research company’s stock after selling 1,520 shares during the quarter. US Bancorp DE’s holdings in Agilent Technologies were worth $6,942,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Stone House Investment Management LLC acquired a new stake in shares of Agilent Technologies during the first quarter worth approximately $30,000. Opal Wealth Advisors LLC acquired a new stake in shares of Agilent Technologies during the first quarter worth approximately $31,000. Ransom Advisory Ltd acquired a new stake in shares of Agilent Technologies during the first quarter worth approximately $32,000. Central Pacific Bank Trust Division acquired a new stake in shares of Agilent Technologies during the second quarter worth approximately $33,000. Finally, Zions Bancorporation National Association UT acquired a new stake in shares of Agilent Technologies during the first quarter worth approximately $38,000.

Agilent Technologies Stock Performance

A stock opened at $136.62 on Monday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. The stock has a market capitalization of $38.73 billion, a price-to-earnings ratio of 32.07, a PEG ratio of 4.46 and a beta of 1.26. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The stock’s fifty day moving average is $125.04 and its two-hundred day moving average is $117.02.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.37. The company had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same period last year, the business posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, research analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Tuesday, September 30th. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.24%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on A shares. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Friday, October 3rd. Evercore ISI raised their price objective on Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 7th. Robert W. Baird raised their price objective on Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a research note on Thursday, August 28th. JPMorgan Chase & Co. raised their price objective on Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research note on Thursday. Finally, Rothschild Redb upgraded Agilent Technologies to a “strong-buy” rating in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $148.69.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.